วันที่ 15 ตุลาคม 2545 1 NO. (SUTHA-SET) 016/2019/EN 14 August 2019 Subject : Clarification of Q2/2019 the total revenues and the Net profit change more than 20% To : The President of the Stock
purchasing power. Performance Analysis Unit : MB For the period ended 31 March 2018 31 March 2017 Change MB % Net sales 261.84 255.90 5.94 2.32 Other income 13.06 10.57 2.49 23.56 Total revenues 274.90 266.47
year were as highlighted below; (Unit : Million Baht) Separate financial statements Q2/2018 Q2/2017 % Change Sales 469 521 (10) Gross Profit Margin 379 396 (4) Selling and Administrative Expenses 54 51 6
tally with consolidated financials due to holding segment. 3Core EBITDA is Reported EBITDA less Inventory gains/(losses). 4Core Net Profit is Reported Net Profit less Inventory gains/(losses) and one-time
change of scoring criteria effective this year despite an increase of average number of registered patients to 176,554 from 164,812 person yoy. Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9
ended as of September 30, 2021, which can be summarized as follows: 1) Profit & Loss Analysis : Q3 2021 (3 Months) (Unit : Million Baht unless otherwise stated) Q3 2021 Q3 2020 Change Amount % Change
) operating results based on its reviewed consolidated financial statements ended 31 March 2019 as follows. Highlights on Q1-2019 Operating results Unit : Million Baht Q1-19 Q1-18 Q4-18 % Change Amount % Amount
) operating results based on its reviewed consolidated financial statements ended 30 June 2018 as follows. Highlights on Q2-2018 Operating results Unit : Million Baht Q2-18 Q2-17 Q1-18 % Change Amount % Amount
) operating results based on its reviewed consolidated financial statements ended 30 September 2018 as follows. Highlights on Q3-2018 Operating results Unit : Million Baht Q3-18 Q3-17 Q2-18 % Change Amount
For the three-month periods ended 30 September Change For the nine-month periods ended 30 September Change 2020 2019 Amount % 2020 2019 Amount % Revenue from sales 224.97 233.67 -8.70 -3.7% 706.95